Dive deeper
Clinical publications
47 publications found.
Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments
Background: Fiducial markers are frequently used before treatment for imageguided patient setup in radiation therapy (RT), but can also be used during treatment for image‐guided intrafraction motion d...
Read moreSafety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
Summary: Gold Anchors were implanted percutaneously via the trans-thoracic route in lung in 80 patients for CyberKnife treatments at the Hartmann Radiotherapy Institute in France. This led to 9 cases ...
Read moreEUS-guided placement of fiducial markers for the treatment of pancreatic cancer
Background (extract): The aim of this video (Video 1, available online at www.VideoGIE.org) is to describe the technique for placement of EUS-guided fiducial markers in the treatment of locally advanc...
Read moreRectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement
Summary: Between 2015 and 2017, 96 patients had 3 Gold Anchor fiducial markers placed in conjunction with transperineal SpaceOar placement into the prostate at the University of Florida Health Proton ...
Read more[OA126] Intrafractional imaging during volumetric modulated arc therapy (VMAT) prostate treatment in combination with gold anchor fiducials
Purpose: Triggered imaging is the use of kV image acquisition during treatment delivery to monitor intrafractional motion of implanted fiducials. An automatically identified fiducial point on the kV i...
Read moreMRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer
Background and purpose: A GTV boost is suggested to result in higher complete response rates in rectal cancer patients, which is attractive for organ preservation. Fiducials may offer GTV position ver...
Read moreLow Infection Rate After Transrectal Implantation of Gold Anchor ™ Fiducial Markers in Prostate Cancer Patients After Non-broad-spectrum Antibiotic Prophylaxis
Abstract: In 621 consecutive prostate cancer patients, the frequency of urinary tract infections (UTI) and marker loss was evaluated. They prophylactically received a single dose of non-broad-spectrum...
Read morePercutaneous ultrasound-guided fiducial marker placement for liver cancer robotic stereotactic radio-surgery treatment: A comparative analysis of three types of markers and needles
Summary: In Italy, ultrasound guided implantation in liver was performed in 50 patients of 68 gold grain markers 1×4 mm through 17-gauge needles, 78 Gold Anchors 0.4×10 mm through 22-gauge needles, an...
Read moreClinical Implications of a Novel, Iron-containing Fiducial Marker in Radiotherapy for Liver Tumors: An Initial Experience
Summary: Gold Anchors were implanted percutaneously under local anesthesia close to liver tumors in four patients at the Meiwa Hospital in Japan. All implantations were successfully performed with no ...
Read moreThe advantage of iron-containing fiducial markers placed with a thin needle for radiotherapy of liver cancer in terms of visualization on MRI: an initial experience of Gold Anchor
Summary: Gold Anchors were implanted through 22-gauge needle in two liver cancer patients at the Gifu Municipal Hospital in Japan. This caused little pain during placement under local anesthesia with ...
Read more